FAKTOR OPTIONSSCHEIN - AMGEN | Real-time BOERSE MUENCHEN 20:45:34 10/05/2024 BST | ||
| 7.98 EUR | +1.40% |
|
| Current month | -27.60% | ||
| 1 month | -29.23% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/05/24 | 7.98 | +1.40% | 0 |
| 09/05/24 | 7.87 | -5.18% | 0 |
| 08/05/24 | 8.3 | -3.94% | 0 |
| 07/05/24 | 8.64 | 0.00% | 0 |
| 06/05/24 | 8.64 | +6.01% | 0 |
Real-time BOERSE MUENCHEN
Last update May 10, 2024 at 08:45 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD2VEE |
| ISIN | DE000HD2VEE3 |
| Date issued | 21/02/2024 |
| Strike | 469.3 $ |
| Maturity | Unlimited |
| Parity | 18.75 : 1 |
| Emission price | 10.17 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.99 € |
|---|---|
| Lowest since issue | 7.59 € |
| Spread | 0.01 € |
| Spread % | 0.13% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.9
USD
Average target price
313.8
USD
Spread / Average Target
+0.30%
- Stock Market
- Certificates
- Certificat
